Your session is about to expire
← Back to Search
Vision Training for Age-Related Macular Degeneration (FLAP Trial)
FLAP Trial Summary
This trial seeks to better understand how the brain adapts to vision loss in order to develop new therapies to improve quality of life for those with low vision.
FLAP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFLAP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FLAP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My medical records show my condition has been severe for at least 2 years.You weigh more than 300 pounds.You have had a severe head injury in the past.You have too many, or very colorful tattoos, especially near your head.I experience hallucinations or delusions.My body's widest part is over 60 inches.I am between 18 and 89 years old.You have braces or a permanent retainer.I am hearing-impaired.You have very poor vision in both eyes (20/100 or worse).You are afraid of being in small, enclosed spaces.I have been diagnosed with Macular Degeneration by an eye doctor.You have sensitivity to light in the central part of your retina that is at least 10 dB units worse than in the outer parts, as shown by a special eye test called a scanning laser ophthalmoscope.You have a pacemaker or metal implanted in your body.
- Group 1: Combination training
- Group 2: Training visual sensitivity
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an opportunity for me to partake in this research?
"This clinical trial seeks to enroll 60 individuals with macular degeneration aged between 18 and 89 years old. In order to be eligible, they must also have severely impaired vision in both eyes (20/100 or worse), a prior diagnosis of Macular Degeneration by an Ophthalmologist, light sensitivity in the macula that is at least 10 dB units more than peripheral regions as confirmed using MAIA technology scans, and documented evidence indicating a minimum two year period of this level of eye disease severity."
Is the recruitment process for this experiment still open?
"Affirmed, the clinical trial is currently recruiting participants. The data posted on clinicaltrials.gov indicates that this experiment was initiated November 1st 2022 and its records were most recently amended October 31st 2022."
How many participants has this research initiative recruited?
"Affirmative, the clinicaltrials.gov website states that this trial is currently seeking participants. It was first posted on November 1st 2022 and has seen its last update on October 31st 2022. 60 patients are planned to be enrolled from a single medical site."
Does this trial accept participants aged twenty or more?
"This trial is seeking adult participants aged 18 and under 89."
Share this study with friends
Copy Link
Messenger